In last trading session, Alignment Healthcare Inc (NASDAQ:ALHC) saw 1.83 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price level of $18.30 trading at $0.14 or 0.77% at ring of the bell on the day assigns it a market valuation of $3.51B. That closing price of ALHC’s stock is at a discount of -15.08% from its 52-week high price of $21.06 and is indicating a premium of 73.17% from its 52-week low price of $4.91. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.05 million shares which gives us an average trading volume of 2.69 million if we extend that period to 3-months.
For Alignment Healthcare Inc (ALHC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 10 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.07 in the current quarter.
Alignment Healthcare Inc (NASDAQ:ALHC) trade information
Upright in the green during last session for gaining 0.77%, in the last five days ALHC remained trading in the red while hitting it’s week-highest on Wednesday, 04/16/25 when the stock touched $18.30 price level, adding 8.41% to its value on the day. Alignment Healthcare Inc’s shares saw a change of 62.67% in year-to-date performance and have moved -5.82% in past 5-day. Alignment Healthcare Inc (NASDAQ:ALHC) showed a performance of 4.81% in past 30-days. Number of shares sold short was 9.5 million shares which calculate 3.38 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a fall of -22.0% to its current value. Analysts have been projecting 9 as a low price target for the stock while placing it at a high target of 21. It follows that stock’s current price would jump 50.82% in reaching the projected high whereas dropping to the targeted low would mean a gain of 50.82% for stock’s current value.
Alignment Healthcare Inc (ALHC) estimates and forecasts
This year revenue growth is estimated to rise 38.64% from the last financial year’s standing.
10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 888.26M for the same. And 10 analysts are in estimates of company making revenue of 945.89M in the next quarter. Company posted 628.6M and 681.29M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -22.95% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 44.16% while estimates for its earnings growth in next 5 years are of 62.27%.
Alignment Healthcare Inc (NASDAQ:ALHC)’s Major holders
Insiders are in possession of 7.37% of company’s total shares while institution are holding 92.61 percent of that, with stock having share float percentage of 99.98%. Investors also watch the number of corporate investors in a company very closely, which is 92.61% institutions for Alignment Healthcare Inc that are currently holding shares of the company. GENERAL ATLANTIC, L.P. is the top institutional holder at ALHC for having 60.99 million shares of worth $476.97 million. And as of 2024-06-30, it was holding 31.9518 of the company’s outstanding shares.
The second largest institutional holder is WARBURG PINCUS LLC, which was holding about 17.92 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.389 of outstanding shares, having a total worth of $140.16 million.
On the other hand, Fidelity Select Portfolios-Health Care Portfolio and Manager Directed Portfolios-Hood River Small-Cap Growth Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 3.4 shares of worth $62.22 million or 1.77% of the total outstanding shares. The later fund manager was in possession of 3.05 shares on Dec 31, 2024 , making its stake of worth around $55.84 million in the company or a holder of 1.59% of company’s stock.
